Detalhe da pesquisa
1.
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.
Cell
; 140(5): 652-65, 2010 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211135
2.
Primary results of patients with genitourinary malignancies presented at a Molecular Tumor Board.
Urol Int
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626735
3.
Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With Stroke.
Stroke
; 54(4): 938-946, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36789775
4.
Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms.
Blood
; 131(18): 2065-2073, 2018 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29519804
5.
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
Ann Hematol
; 99(7): 1551-1560, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32504186
6.
Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcome.
Haematologica
; 104(1): 59-69, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171030
7.
Root system size response of bzh semi-dwarf oilseed rape hybrids to different nitrogen levels in the field.
Ann Bot
; 124(6): 891-901, 2019 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30452536
8.
Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment.
Br J Haematol
; 182(6): 830-842, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29974943
9.
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial).
Br J Haematol
; 183(2): 235-241, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30378121
10.
Activity of decitabine combined with all-trans retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER).
Haematologica
; 108(8): 2244-2248, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601981
11.
DArT, SNP, and SSR analyses of genetic diversity in Lolium perenne L. using bulk sampling.
BMC Genet
; 19(1): 10, 2018 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29357832
12.
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.
Ann Hematol
; 97(10): 1785-1795, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29926156
13.
Ruxolitinib.
Recent Results Cancer Res
; 212: 119-132, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30069628
14.
Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5-aza-2'-deoxycytidine (Decitabine).
Br J Haematol
; 176(4): 609-617, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27905102
15.
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
Blood
; 125(3): 499-503, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25343957
16.
Tracing the development of acute myeloid leukemia in CBL syndrome.
Blood
; 123(12): 1883-6, 2014 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24493670
17.
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group.
Ann Hematol
; 95(2): 191-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26596971
18.
Blastic transformation of BCR-ABL1 positive chronic myeloid leukaemia through acquisition of CBFB-MYH11 and mutant KIT.
Br J Haematol
; 190(6): e339-e343, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32579287
19.
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.
Blood
; 121(2): 385-91, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23160462
20.
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Blood
; 121(1): 159-69, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100311